New Review Article Published by the Xiang Lab in Onco Targets Ther

Novel EXO-T vaccine using polyclonal CD4+ T cells armed with HER2-specific exosomes for HER2-positive breast cancer

Authors: Li R, Chibbar R, Xiang J.

Onco Targets Ther. 2018 Oct 17;11:7089-7093. doi: 10.2147/OTT.S184898. eCollection 2018. Review.

PMID: 30410365

 

This paper can be accessed here: https://www.ncbi.nlm.nih.gov/pubmed/30410365